Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) had Cash Flow from Financial Activities of $8.03M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$12.01M |
|
$0.25M |
|
$7.79M |
|
$19.80M |
|
$3.31M |
|
-- |
|
$1.21M |
|
$4.53M |
|
$15.27M |
|
$7.73M |
|
$15.27M |
|
0.62M |
|
| Cash Flow Statement Financials | |
$-4.41M |
|
$-0.45M |
|
|
Cash Flow from Financial Activities |
$8.03M |
$2.23M |
|
$5.39M |
|
$3.16M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|